SWOT Analysis - PharmaSim Case

docx

School

Georgia Southwestern State University *

*We aren’t endorsed by this school

Course

6120

Subject

Marketing

Date

Feb 20, 2024

Type

docx

Pages

2

Uploaded by ProfRoseRaccoon29

Report
SWOT Analysis - The PharmaSim Case Study Internal and external factors of PharmaSim: Internal Factors Strengths Weaknesses Management High Market Share High Prices Strong Brand Reputation Dependency on Cold Segment Lower Fixed Costs Need for Constant Innovation High Conversion Ratio Limited Product Range Diversification Potential Dependence on Formulation External Factors Opportunities Threats Consumer / Social Expansion into Other Customer Segments Competitor Aggression Use of social media Price Sensitivity Product Diversification Population Growth Product Reformulation Regulatory Changes Direct to Consumer Promotions Consumer Preferences Strengths PharmaSim presents several internal strengths that affect its position in the over- the-counter (OTC) cold and allergy medicine market. One of its advantages is its high market share, which makes it second best in the OTC. This large presence is evidence of the brand's popularity and consumer acceptance. Specifically, the Allround brand has a strong reputation on the market because of its competence. This competence allows PharmaSim to charge more for its products than those supplied by competitors. A strong brand reputation is also a competitive advantage and helps strengthen that company's market power. Another internal advantage of PharmaSim is that its fixed costs are lower than those of its competitors. This cost advantage makes the firm more profitable and stimulates its response to pricing strategies. Also, PharmaSim has a high conversion rate, implying that an significant percentage of potential clients buy (Kinnear et al., 2023). This is a positive sign of customer satisfaction and effectively converting interest to sales. Beyond that, the firm has an opportunity for diversification because it can increase product lines outside of the cold remedy, leading to more market penetration and a rise in sales. Weaknesses However, PharmaSim does have its internal weaknesses. Although high prices indicate the effectiveness of its products, this limits the market share, particularly price- sensitive consumers. This is problematic for the firm as it seeks to balance keeping premium pricing and the need for greater market penetration. PharmaSim's sales rely largely on the cold remedy of the OTC market, making it vulnerable if demand for these remedies falls (Kinnear et al., 2023). This dependence is something that the company must address to secure sustained growth and stability against fluctuations in market conditions.
The pharmaceutical industry is highly competitive and demands constant innovation, a weakness that PharmaSim recognizes. The company should remain aware of its rivals' new products and marketing strategies to ensure that it leads in market shares. Moreover, the range of PharmaSim’s products is limited because they cover cold symptoms only. However, this restrictive product range may limit its market size and growth potential. Moreover, PharmaSim's success is highly dependent on the formulation of its Allround product. Any changes in ingredients can affect their efficacy and therefore sales performance. Opportunities Externally, PharmaSim's future seems full of opportunities for ventures that can boost its position in terms of market standing. Such an opportunity includes the next possible step in another customer segment, such as cough, allergies, and many more symptoms. PharmaSim can expand its current customer, which, in turn, would widen its earning potential (Singh & Chakraborty, 2023). The company can also use the opportunity to capitalize on social media to establish a relationship with younger generations. Product diversification is a clear and long-term external opportunity that PharmaSim can exploit to maintain its significance in a lukewarm market. Another direction for the possible development of market share and profitability overgrowth is to adapt its products in relation to age groups and different health conditions. Besides, direct- to-consumer promotions are derived straight from the manufacturer to potential consumers, thus providing a business advantage through directly captivating buyers. Threats Although PharmaSim can take advantage of these opportunities, the company is not immune to external threats. Niche products for non-penetrated customer segments, and a competitive attack-based aggressive marketing strategy will threaten Allround’s market share and retention ratio. A significant factor in the industry is price sensitivity among consumers, which may also adversely affect PharmaSim's market share (Singh & Chakraborty, 2023). As well as changes in regulations for over-the-counter medicines, consumer preferences toward natural or organic products, and pressures on resources and capacity due to population growth pose threats that the company has to deal with.
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
  • Access to all documents
  • Unlimited textbook solutions
  • 24/7 expert homework help